Showing 1 - 20 results of 28 for search '"HER2/neu"', query time: 0.07s Refine Results
  1. 1

    A study on the expression of Her2/neu in malignant epithelial ovarian tumors by Amit Kumar Bhardwaj, Vanita Bhaskar, Rashmi Nayak, Anubhav Chandrakar, Vikas Bombeshwar, Vikas Kailashiya

    Published 2024-12-01
    “…A review of the literature highlights a wide range of Her2/neu overexpression or amplifications in ovarian tumors, with reported rates between 8% and 66%. …”
    Get full text
    Article
  2. 2
  3. 3

    Intradermal DNA Electroporation Induces Cellular and Humoral Immune Response and Confers Protection against HER2/neu Tumor by Alessia Lamolinara, Lorenzo Stramucci, Albana Hysi, Manuela Iezzi, Cristina Marchini, Marianna Mariotti, Augusto Amici, Claudia Curcio

    Published 2015-01-01
    “…Moreover, we tested the efficacy of intradermal vaccination against Her2/neu antigen in cellular and humoral response induction and consequent protection from a Her2/neu tumor challenge in Her2/neu nontolerant and tolerant mice. …”
    Get full text
    Article
  4. 4

    HER-2/neu Amplification Testing in Breast Cancer by Multiplex Ligation-Dependent Probe Amplification in Comparison with Immunohistochemistry and In Situ Hybridization by Cathy B. Moelans, Roel A. de Weger, Marja T.M. van Blokland, Chantal Ezendam, Sabrina Elshof, Marcel G. J. Tilanus, Paul J. van Diest

    Published 2009-01-01
    “…Background: Assessment of HER-2/neu status in invasive breast cancer is crucial to establish eligibility for trastuzumab and taxane based chemotherapy. …”
    Get full text
    Article
  5. 5

    Stromal Expression of CD10 in Invasive Breast Carcinoma and Its Correlation with ER, PR, HER2-neu, and Ki67 by Vandana Puri, Manjula Jain, Shaji Thomas

    Published 2011-01-01
    “…Stromal CD10 showed positive correlation with tumour grade, HER2-neu (P=.000), and ki67 (P=.027), negative correlation with ER and PR. …”
    Get full text
    Article
  6. 6
  7. 7

    HER-2/neu 基因表达对Ⅲ期非小细胞肺癌化疗敏感性的影响 by 程 超, 吴一龙, 谷力加, 翁毅敏, 冯卫能, 钟文钊, 黄邵洪

    Published 2002-01-01
    “…【目的】探讨 HER-2/neu 基因表达对Ⅲ期 NSCLC 化疗敏感性的影响。【方法】对22 例中晚期 NSCLC 患者术前化疗后行手术治 疗,标本采用免疫组化法进行 HER-2/neu 检测,分析HER-2/neu 与化疗显效率、疾病进展时间( TTP)的关系。…”
    Get full text
    Article
  8. 8

    LEAPS Vaccine Incorporating HER-2/neu Epitope Elicits Protection That Prevents and Limits Tumor Growth and Spread of Breast Cancer in a Mouse Model by Ken S. Rosenthal, Sarah Stone, Gary Koski, Daniel H. Zimmerman

    Published 2017-01-01
    “…The prototype J-LEAPS T cell vaccine for HER-2/neu breast cancer (J-HER) consists of the murine HER-2/neu66–74 H-2d CD8 T cell epitope covalently attached through a triglycine linker to the J-immune cell binding ligand (ICBL) (human β2 microglobulin38–50 peptide). …”
    Get full text
    Article
  9. 9

    Intraoperative Imaging of Positron Emission Tomographic Radiotracers Using Cerenkov Luminescence Emissions by Jason P. Holland, Guillaume Normand, Alessandro Ruggiero, Jason S. Lewis, Jan Grimm

    Published 2011-05-01
    “…CLI, PET, and biodistribution studies revealed target-specific uptake of 89 Zr-DFO-trastuzumab in BT-474 ( HER2/neu positive) versus MDA-MB-468 ( HER2/neu negative) xenografts in the same mice. …”
    Get full text
    Article
  10. 10

    Ribociclib-induced vitiligo in a case of metastatic carcinoma of the breast by Abhira Deb, Manthan Dhingra, Srutee Barman, Thinakaran Raja, Abhra Ghosh

    Published 2025-01-01
    “…This report presents a case of HR+ and HER2/neu− metastatic breast carcinoma treated with CDK4/6 inhibitor plus endocrine therapy with the development of vitiligo during the treatment.…”
    Get full text
    Article
  11. 11

    Assessment of Tissue Eosinophilic Infiltration in Invasive Mammary Carcinoma by Farah Falah Hasan, Mohammed Haider Fadhil, Zainab Khalid Almukhtar

    Published 2024-01-01
    “…The presence of tissue eosinophilic infiltration can predict HER2/NEU negativity in breast cancer.…”
    Get full text
    Article
  12. 12

    Biomarker panel for early detection of uterine cancer by Nemali Deepthi Deepthi Priya, NANDA KUMAR K V, DEVARAJAPPAGARI BINDU, KASIREDDY LIKHITHA, MEKALA SIVA CHARANI

    Published 2024-10-01
    “…Several biomarkers, including P53, K-RAS, CA-125, HER2/neu, HE4, PTEN, MSI are used for early detection, treatment, and prevention of uterine cancer. …”
    Get full text
    Article
  13. 13

    Papillary Carcinoma of Breast: Clinicopathological Characteristics, Management, and Survival by Bushra Rehman, Anam Mumtaz, Barka Sajjad, Namra Urooj, Sameen Mohtasham Khan, M. Toqeer Zahid, Huma Mannan, M. Zulqarnain Chaudhary, Amina Khan, M. Asad Parvaiz

    Published 2022-01-01
    “…Only two patients were ER negative (both IPC). HER-2 Neu was positive in 3 patients only, out of which 2 died of progressive disease (one EPC and one IPC). …”
    Get full text
    Article
  14. 14

    Comparing the Prognostic Value of PTEN and Akt Expression with the Mitotic Activity Index in Adjuvant Chemotherapy-Treated Node-Negative Breast Cancer patients aged <55 years by Emiel A. M. Janssen, Håvard Søiland, Ivar Skaland, Einar Gudlaugson, Kjell H. Kjellevold, Arne Nysted, Jon-Arne Søreide, Jan P. A. Baak

    Published 2007-01-01
    “…The MAI was the strongest prognosticator (Hazard Ratio = HR = 2.9, p = 0.01). Her2Neu/p110α/Akt/mTOR features have no additional prognostic value to the MAI. …”
    Get full text
    Article
  15. 15

    A Rare Case Report: Primary Vulvar Adenocarcinoma of Mammary Gland Type by Dai X, Lei H, Jie R

    Published 2025-02-01
    “…The tumor cells were positive for SOX10, TRPS1, and E-cadherin, and negative for ER, PR, and HER-2/neu, ruling out metastatic breast carcinoma. …”
    Get full text
    Article
  16. 16

    Contrast-Enhanced Mammography in the Diagnosis of Breast Angiosarcoma by Maya Grisaru Kacen, Nikhil Sangle, Anat Kornecki

    Published 2021-01-01
    “…She had a history of a stage I (T1bN0M0) right breast invasive mammary carcinoma, grade 2 (score 7/9) with receptors ER/PR-negative, HER2/neu-positive, diagnosed four years prior to her current presentation. …”
    Get full text
    Article
  17. 17

    Metaplastic Carcinoma Breast in Polycythemic Octogenarian – Lessons Learnt: Case Report by Swarup Prabhu, Munish Malhotra, Naresh Saidha, Ritu Mehta, Surjeet Dwivedi, Tarun Mohan Gupta

    Published 2024-09-01
    “…Clinically was aT4b lesion, sonomammogram showed BIRADS V lesion and core needle breast biopsy features were suggestive of metaplastic carcinoma breast of adenosquamous type, ER, PR-Positive, Her2Neu-Negative. Patient received preoperative hormonal therapy followed by modified radical mastectomy and postoperative adjuvant chemotherapy and hormonal therapy. …”
    Get full text
    Article
  18. 18

    Molecular Subtypes of Breast Carcinoma and Their Association with Clinicopathological Features by Ambreen Bari, Sumayyah Shawana

    Published 2025-01-01
    “…Immunohistochemical analysis was done for ER, PR, HER 2 Neu, and Ki-67 and the findings were statistically analyzed for association with clinicopathological parameters. …”
    Get full text
    Article
  19. 19

    Metastatic Extramammary Paget’s Disease of Scrotum Responds Completely to Single Agent Trastuzumab in a Hemodialysis Patient: Case Report, Molecular Profiling and Brief Review of t... by Peter Barth, Essel Dulaimi Al-Saleem, Kristin W. Edwards, Sherri Z. Millis, Yu-Ning Wong, Daniel M. Geynisman

    Published 2015-01-01
    “…We report a case of a complete response to single agent trastuzumab in a hemodialysis patient with metastatic Her2/neu overexpressed EMPD of the scrotum. Molecular profiling of his case as well as 12 other EMPD and 8 mammary Paget disease (MPD) cases was completed and revealed multiple biomarker aberrations. …”
    Get full text
    Article
  20. 20

    Lymphoepithelioma-Like Carcinoma of the Breast: A Case Report Unveiling Several Clinical and Histopathological Challenges by Tarek Aridi, Mohamad Fawwaz, Ahmad Kassab, Marwan Bahmad, Faisal Houcheimi, Mohamad Mshiek, Fouad Boulos, Ali Kanj, Ghassan Ramadan, Hisham F. Bahmad, Najla Fakhruddin

    Published 2018-01-01
    “…The tumor is negative for estrogen and progesterone receptors and did not overexpress HER2/neu. Routine tests for clearance before surgery were performed, and patient was managed by a modified radical mastectomy with axillary lymph node dissection showing no residual tumor. …”
    Get full text
    Article